Elizabeth Jung

415 total citations
9 papers, 303 citations indexed

About

Elizabeth Jung is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elizabeth Jung has authored 9 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Elizabeth Jung's work include Neonatal Respiratory Health Research (3 papers), Neutropenia and Cancer Infections (2 papers) and Complement system in diseases (2 papers). Elizabeth Jung is often cited by papers focused on Neonatal Respiratory Health Research (3 papers), Neutropenia and Cancer Infections (2 papers) and Complement system in diseases (2 papers). Elizabeth Jung collaborates with scholars based in United States, Canada and Czechia. Elizabeth Jung's co-authors include Robert L. Schelonka, Barry T. Bloom, Karen Kesler, Seth Hetherington, Fabien Eyal, Yiting Liu, David J. Burchfield, Amy Morris, Hesso Farhan and Barry Kapik and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Pediatrics and Pediatric Research.

In The Last Decade

Elizabeth Jung

9 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Jung United States 6 132 104 81 67 52 9 303
Longkun Zhu United States 11 61 0.5× 123 1.2× 80 1.0× 22 0.3× 62 1.2× 12 347
Yong-Jin Yang South Korea 12 73 0.6× 225 2.2× 105 1.3× 36 0.5× 18 0.3× 24 435
Z. Fitouri Tunisia 10 71 0.5× 59 0.6× 44 0.5× 50 0.7× 53 1.0× 28 301
Giulia Calenda United States 12 72 0.5× 71 0.7× 63 0.8× 19 0.3× 67 1.3× 22 371
Ingela Nilsson Sweden 11 41 0.3× 58 0.6× 82 1.0× 34 0.5× 21 0.4× 19 367
Marianne Brabec Austria 10 47 0.4× 169 1.6× 71 0.9× 45 0.7× 63 1.2× 11 427
Luciano D’Attilio Argentina 13 151 1.1× 133 1.3× 190 2.3× 47 0.7× 145 2.8× 29 525
Yanjuan Jia China 11 76 0.6× 115 1.1× 84 1.0× 14 0.2× 64 1.2× 21 381
Yuxin Ran China 12 119 0.9× 138 1.3× 79 1.0× 36 0.5× 78 1.5× 30 427
P. Montanari Italy 13 31 0.2× 148 1.4× 82 1.0× 52 0.8× 65 1.3× 32 541

Countries citing papers authored by Elizabeth Jung

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Jung more than expected).

Fields of papers citing papers by Elizabeth Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Jung. The network helps show where Elizabeth Jung may publish in the future.

Co-authorship network of co-authors of Elizabeth Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Jung. A scholar is included among the top collaborators of Elizabeth Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Jung. Elizabeth Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jung, Elizabeth, et al.. (2023). A new care pathway to optimize gestational weight gain in twin pregnancies. American Journal of Obstetrics & Gynecology MFM. 5(8). 101018–101018. 3 indexed citations
3.
Abarca, Katia, Elizabeth Jung, Liang Zhao, et al.. (2009). Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Motavizumab, a Humanized, Enhanced-Potency Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus Infection in At-Risk Children. The Pediatric Infectious Disease Journal. 28(4). 267–272. 44 indexed citations
4.
Ruggiero, Alicia M., Yiting Liu, Svetlana Vidensky, et al.. (2008). The Endoplasmic Reticulum Exit of Glutamate Transporter Is Regulated by the Inducible Mammalian Yip6b/GTRAP3-18 Protein. Journal of Biological Chemistry. 283(10). 6175–6183. 63 indexed citations
5.
Burchfield, David J., Barry T. Bloom, Mark J. Polak, et al.. (2007). Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants. The Journal of Pediatrics. 151(3). 260–265.e1. 114 indexed citations
6.
Bloom, Barry T., Robert L. Schelonka, Elizabeth Jung, et al.. (2005). Multicenter Study to Assess Safety and Efficacy of INH-A21, a Donor-Selected Human Staphylococcal Immunoglobulin, for Prevention of Nosocomial Infections in Very Low Birth Weight Infants. The Pediatric Infectious Disease Journal. 24(10). 858–866. 44 indexed citations
7.
Jung, Elizabeth, et al.. (1998). Complement Component C9 Enhances the Capacity of Beta-Lactam Antibiotics to Kill Escherichia coli In Vitro and In Vivo. The American Journal of the Medical Sciences. 315(5). 307–313. 3 indexed citations
8.
Jung, Elizabeth, et al.. (1998). Complement Component C9 Enhances the Capacity of Beta-Lactam Antibiotics to Kill Escherichia coli In Vitro and In Vivo. The American Journal of the Medical Sciences. 315(5). 307–313. 6 indexed citations
9.
Lassiter, Herbert A., Jessica L. Wilson, Elizabeth Jung, et al.. (1997). The Administration of Complement Component C9 Enhances the Survival of Neonatal Rats with Escherichia coli Sepsis1. Pediatric Research. 42(1). 128–136. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026